Cargando…
Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
Background: Despite the significant survival benefits of anti-PD-1/PD-L1 immunotherapy, non-small cell lung cancer (NSCLC) remains one of the most common tumors and major causes of cancer-related deaths worldwide. Thus, there is an urgent need to identify new therapeutic targets for this refractory...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060803/ https://www.ncbi.nlm.nih.gov/pubmed/37007961 http://dx.doi.org/10.3389/fgene.2023.1139994 |